RetractedArticleClinical Medicine Insights. Oncology2021

MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.

Zhongbo Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.